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Abstract The bacterial toxin VacA produced by H. pylori
induces large vacuoles in several types of cultured cells such as
HeLa cells or gastric cells. To determine the mechanism of
vacuolation induced by this toxin we employed several inhibitors
of membrane trafficking and endocytosis. The development of
vacuolation induced by VacA in HeLa cells were prevented by
bafilomycin A1 and low temperature conditions that inhibited
vesicle transport or endocytosis. Formation of large vacuoles was
also inhibited by an antibody against EGF receptor, which was
previously shown to be internalized by endocytosis, but not by an
anti-transferrin receptor antibody. Moreover, proteins of 58 and
37 kDa, corresponding to fragments of VacA, were recognized
by an anti-H. pylori antibody after immunoprecipitation with
anti-EGF receptor of cell extracts from HeLa cells treated with
VacA, but not from untreated HeLa cells. We suggest that VacA
may enter cells by endocytosis mediated by the EGF receptor.
These are the first data indicating that the EGF receptor may be
significant in the development of vacuolation caused by VacA.
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1. Introduction
Helicobacter pylori (H. pylori) is a micro-aerophilic, Gram-
negative, spiral bacterium that infects more than 50% of the
human population [1]. H. pylori plays a major role in the
development of gastritis, peptic ulcer disease, and gastric car-
cinoma [2]. It is known that H. pylori produces a vacuolating
toxin, VacA [3], and several other cytotoxins such as CagA
[4], NapA [5], and PicB [6].
VacA is translated as a 140-kDa pre-pro protein and is
cleaved at the N-terminal 33 amino acid leader sequence in
the periplasm and at the C-terminal 55-kDa peptide domain
in the outer membrane, and then is released from the organ-
ism as a 95-kDa mature protein [7]. The released VacA can be
cleaved into two fragments of molecular weights 58 kDa and
37 kDa [7,8], but this protein forms complexes of more than
1000 kDa under non-denaturing conditions [9]. It has been
reported that VacA has a ‘£ower’ like oligometric structure
[10,11]. It is known that VacA induces large vacuoles in cul-
tured cells [12,13] and in animal cells in vivo [14]. Previous
studies have shown that the vacuoles in HeLa cells caused by
VacA are enriched in rab7, a small GTP-binding protein as-
sociated with the late endosomal component [12,15]. Domi-
nant negative rab7 mutation prevents vacuolation caused by
VacA. It is also known that vacuolation is inhibited by ba¢-
lomycin A1, which is a speci¢c V-type ATPase inhibitor [12],
or by addition of an anti-V-type ATPase antibody [16]. In
addition, it has been reported that ba¢lomycin A1 can inhibit
the transition from early to late endosome [17] and it is being
investigated whether the late endosome is a key component in
vacuolation caused by VacA.
Many bacterial toxins are internalized into eukaryotic cells.
For example, it is known that diphtheria toxin enters cells and
then enzymatically modi¢es a speci¢c intracellular target [18].
It has been reported that VacA is associated with the plasma
membrane of eukaryotic cells and is then internalized [19].
The important subunit of VacA for internalization seems to
be the C-terminal 58-kDa fragment [19]. However, the mech-
anism by which the toxin enters the cells is not clear and the
receptor or ligand on the plasma membrane has not been
de¢ned.
In this study, we have investigated the mechanism of inter-
nalization of VacA in cultured cells and the receptor on the
membrane of host cells that binds with VacA.
2. Material and methods
2.1. Materials
Brucella broth was purchased from Difco Laboratories (Detroit,
MI, USA). RPMI 1640 medium was obtained from Gibco Laborato-
ries (Grand Island, NY, USA). Ba¢lomycin A1, neutral red, and L-
cyclodextrin were purchased from Wako Chemicals (Osaka, Japan).
Fetal bovine serum was obtained from Dai-nihon Pharmaceuticals
(Osaka, Japan). Antibiotic-antimycological solution was purchased
from Sigma Chemical Co. (St. Louis, MO, USA). Anti-EGF receptor
antibody directed against the extracellular domain was obtained from
Monosan (the Netherlands). Mouse IgG was obtained from Vector
Laboratories (Burlingame, CA, USA). Anti-transferrin receptor anti-
body was obtained from Austral Biologicals (Son Ramon, CA, USA).
Protein G-agarose was obtained from Calbiochem (Cambridge, MA).
Anti-Helicobacter pylori antibody was obtained from Kirkegaard
Perry Laboratories (Gaithersburg, MD). Anti-EGF receptor antibody
directed against the intracellular domain was obtained from Trans-
duction Laboratories (Lexington, KY, USA). Fluorescein-labeled pro-
tein G was obtained from Bio-Rad Laboratories (Hercules, CA,
USA).
2.2. Bacterial culture and preparation of VacA
H. pylori (ATCC 43504, American type culture collection) was
grown with shaking at 70 rpm in brucella broth containing 5% fetal
bovine serum under microaerophilic conditions (10% CO2, 5% O2,
85% N2) at 37‡C for 24 h. The cultures were centrifuged at 3000
rpm, the medium was removed, and the bacteria were resuspensed
at 107 cfu/ml in brucella broth containing 0.3% L-cyclodextrin without
fetal bovine serum. Then organisms were cultured with shaking at 70
rpm under microaerophilic conditions at 37‡C for 2 days. The cultures
were centrifuged and the supernatants were precipitated with satu-
rated ammonium sulfate (50% saturation). The pellets were re-sus-
pended in phosphate-bu¡ered saline, and were stored at 330‡C until
use.
2.3. Cell culture and assay for cell vacuolation
HeLa cells were cultured in RPMI 1640 containing 10% fetal bovine
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serum in a 96-well culture plate at 37‡C for 3 days. The cells were
incubated with crude extracts containing VacA prepared as described
in Section 2.2 in RPMI 1640 with 10% fetal bovine serum at 37‡C.
The inhibitor ba¢lomycin A1 was added simultaneously to the me-
dium, while antibodies were added 30 min before VacA addition. The
total number of cells and the number of vacuolated cells were
counted. Neutral red uptake was assessed as described by Papini et
al. [12]. Neutral red was incorporated into the cells for 5 min after
treatment with VacA and then the dye was extracted with 40% HCl-
0.37% EtOH, and was detected by UV absorbance at 550 nm. In a
time course experiment, the cells were incubated with VacA for the
indicated times, and then were treated with neutral red for 5 min.
2.4. Immunoprecipitation and Western blot analysis
HeLa cells were treated with toxin fractions containing VacA in
RPMI 1640 for 6 h, and were then harvested with ice cold RIPA
bu¡er (50 mM HEPES, pH 7.4, 150 mM NaCl, 1% Triton X-100,
1 mM EDTA, 1.5 mM MgCl2, 0.1 mM Na2Vo4, 50 mM NaF, 1 mM
PMSF, 1 mM leupeptin, and 10 Wg/ml trypsin inhibitor) and homo-
genized using a syringe. The cell lysates were pretreated with protein
G-agarose solution and centrifuged at 15 000 rpm for 20 min. The
supernatants were treated with anti-EGF receptor directed against
the internal domain of the receptor, and were incubated with protein
G-agarose solution. After centrifugation, the pellets were solubilized
in SDS-PAGE sample bu¡er, and aliquots were loaded onto the gels
[20]. The proteins thus obtained were transferred to a nylon mem-
brane, and were incubated in PBS with 0.1% Tween 20, and 3% non-
fat milk containing anti-H. pylori antibody. After washing, the pro-
teins were detected by HRP-labeled protein G using an ECL detection
kit (Amersham-Pharmacia, Buckinghamshire, UK).
3. Results
3.1. Microscopy of large vacuoles induced by VacA
As shown in Fig. 1, vacuoles were induced by the crude
extract containing VacA obtained from the culture medium
of H. pylori as described in Section 2. Vacuolated cells com-
prised more than 80% of all cells at low magni¢cation (Fig.
1a,c).
3.2. E¡ect of ba¢lomycin A1 on formation of large vacuoles
As reported previously, neutral red uptake (Fig. 2a) or vac-
uolation of cells (Fig. 2b) induced by VacA were prevented
by ba¢lomycin A1, a V-type ATPase inhibitor that can inhibit
the transition to late endosome from early endosome, or to
the lysosome from late endosome.
3.3. E¡ect of temperature on vacuolation
To determine the role of vesicle transport in the develop-
ment of vacuolation, we investigated whether the vacuolation
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Fig. 1. Vacuole formation induced by VacA. HeLa cells were incu-
bated with (c,d) or without (a,b) VacA crude extract from bacterial
culture medium for 24 h and photographed in high magni¢cation
(a,c) or low magni¢cation (b,d).
Fig. 2. E¡ect of ba¢lomycin on formation of large vacuoles. HeLa
cells were treated with ba¢lomycin A1, and incubated with VacA
for 24 h. A neutral red uptake assay and counting of cells were ana-
lyzed as described in Section 2. Each column represents mean þ S.E.
(n = 6). Statistical analysis is Sche¡es’s test. **P = 0.01 vs. cont.,
***P = 0.001 vs. cont.
Fig. 3. E¡ects of temperature on the development of vacuolation.
HeLa cells were incubated with VacA in conditions at 37‡C (b) or
at 10‡C (a) for the indicated time, and the activity was analyzed by
neutral red uptake assay as described in Section 2. Each point rep-
resents mean þ S.E. (n = 8). Statistical analysis is Student’s t-test.
**P = 0.01 vs. cont.
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is prevented by low temperature that can inhibit the vesicle
transport. As shown in Fig. 3, neutral red uptake was time-
dependently increased by VacA, and was prevented by a low
temperature of 10‡C.
3.4. E¡ect of antibodies against plasma membrane receptors on
vacuolation
To investigate the mechanism of internalization of VacA,
we used antibodies directed against plasma membrane recep-
tors, anti-EGF receptor and anti-transferrin receptor antibod-
ies. As shown in Fig. 4, vacuolation of HeLa cells induced by
the addition of crude VacA extracts was prevented by addi-
tion of anti-EGF receptor antibody directed against the ex-
tracellular domain of the receptor, but not by anti-transferrin
receptor antibody or normal IgG. The number of vacuolated
cells was decreased depending on the concentration of anti-
EGF receptor antibody.
3.5. Association of VacA with EGF-R in the development of
vacuolation
We investigated whether VacA associated with the EGF
receptor using immunoprecipitation and Western blot analy-
sis. Extracts from HeLa cells treated with crude VacA were
immunoprecipitated using an anti-EGF receptor antibody re-
acting with the intracellular domain of the C-terminal region
of EGF receptor, and the immunoprecipitate was analyzed by
SDS-PAGE and Western blotting using an anti-H. pylori anti-
body reacting with VacA. As shown in Fig. 5, proteins of 58
kDa and 37 kDa reacted with anti-H. pylori antibody in the
extracts immunoprecipitated with anti-EGF receptor antibody
from VacA-treated HeLa cells, but not from untreated HeLa
cells.
4. Discussion
We investigated the mechanism of internalization of VacA
into the cells and the cell surface receptor of host cells binding
with VacA. It is already known that the vacuoles in HeLa
cells created by VacA are enriched in rab7, a small GTP-bind-
ing protein previously shown to be associated with the late
endosomal component [12,15]. It has been reported that vac-
uolation induced by VacA is prevented by ba¢lomycin A1, a
V-type ATPase inhibitor [12,16], and this was con¢rmed in
our study (Fig. 2). It is known that ba¢lomycin A1 can inhibit
membrane tra⁄cking to late endosome from early endosome,
or to lysosome from late endosome [17]. Therefore, our results
suggested that the development of vacuolation by VacA was
related to membrane tra⁄cking from early endosome, and not
to the pathway from TGN to late endosome.
It is unclear whether the mechanism of internalization of
VacA involves endocytosis or another pathway. It has been
suggested that VacA is internalized by a non-endocytotic
pathway, because its internalization is slower than that of
other proteins. However, VacA has a high molecular weight
of 95 kDa under denaturing conditions and forms a more
than 1000-kDa complex under non-denaturing conditions
[21], so it would not be able to cross the plasma membrane.
In this study we found that the increase of neutral red uptake
by VacA was rapid and the development of vacuolation was
prevented by low temperature conditions that can inhibit en-
docytotic membrane transport (Fig. 3). As shown in Fig. 4,
vacuolation was also prevented by a monoclonal antibody
against EGF receptor, which was previously shown to be in-
ternalized by endocytosis. These ¢ndings suggest that VacA
may be internalized into cells by endocytosis.
On the other hand, vacuolation was not prevented by a
monoclonal antibody against the transferrin receptor, which
was previously shown to be internalized by endocytosis as well
as the EGF receptor (Fig. 4). Therefore, it may be that the
EGF receptor is important in the internalization of VacA. In
the case of other bacterial toxins, it is reported that diphtheria
toxin is internalized into cells via a cell surface receptor
[18,22]. It is known that this toxin is processed into two frag-
ments and one of the fragments is important for internaliza-
tion [18,23], as is the case for VacA. Thus, internalization of
VacA may mimic that of diphtheria toxin. This study also
showed that anti-H. pylori antibody reacted with the 57-kDa
protein corresponding to one of the fragments of VacA after
immunoprecipitation with anti-EGF receptor antibody of ex-
tracts from cells treated with VacA (Fig. 5). This result sug-
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Fig. 5. Association of VacA with EGF-R on the development of
vacuolation. Extracts from HeLa cells treated with crude VacA
were immunoprecipitated with anti-EGF-R antibody reacting with
the intercellular domain of the C-terminal region in EGF-R, and
the immunoprecipitate was analyzed by SDS-PAGE and Western
blotting using anti-H. pylori antibody reacting with VacA. Lane 1:
H. pylori culture medium precipitated with saturated ammonium
sulfate. Lane 2: Immunoprecipitate of HeLa cells treated with the
crude fraction containing VacA. Lane 3: Non-treated HeLa cells.
Fig. 4. E¡ects of antibodies against receptors in plasma membrane
on the development of vacuolation induced by VacA. After treating
with antibodies for 30 min, HeLa cells were incubated with VacA
for 24 h, and then the total number of cells and vacuolated number
of cells were counted (open column: mouse IgG; closed column:
anti-EGF receptor antibody; dotted column: anti-transferrin recep-
tor antibody). Each column represents mean þ S.E. (n = 6). Statistical
analysis is Sche¡es’s test. ***P = 0.001 vs. normal IgG.
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gests that VacA may be associated with the EGF receptor
directly or indirectly, and that this receptor may be a signi¢-
cant factor in the development of vacuolation by VacA.
It is known that the genotype of VacA is related to the
pathogenesis of gastric in£ammation and peptic ulceration
in patients infected with H. pylori [24]. Infection with H. py-
lori induces apoptosis and causes atrophic gastritis in animal
[25] or man [26]. On the other hand, EGF is one of the most
important factors in gastric wound healing [27]. If VacA com-
petes with EGF for receptor binding, the response to EGF
may be decreased and the rate of cell turnover may also de-
crease. The ¢nal results may be apoptosis or cell atrophy. As
shown in Fig. 4, the vacuolating action of VacA was pre-
vented by anti-EGF receptor monoclonal antibody that can
inhibit actions of EGF. Therefore, it is interred that a binding
site of EGF in the receptor is near the region with that of
VacA and EGF can compete with this toxin for receptor bind-
ing. But we have no evidence whether EGF directly competes
with VacA for receptor binding.
We investigated the mechanism of vacuolation caused by
VacA produced from H. pylori. Our study suggested that the
pathway from early to late endosome is essential to the devel-
opment of vacuolation and that VacA enters the cells by en-
docytosis. The possibility that the EGF receptor is important
in the internalization of VacA was also suggested. These are
the ¢rst data indicating that the EGF-receptor may be in-
volved in the development of vacuolation by VacA, and
they are of interest not only with regard to the cell biologic
action of bacterial toxins but also to the pathogenesis of H.
pylori infection.
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